Anwei Chen

Anwei Chen


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2016 in SpringerPlus
Verified
Journal Article
Open access
PDF file
JXJie Xu
Jie Xu
YWYi-Fei Wang
Yi-Fei Wang
ACAnwei Chen
Anwei Chen
TWTao Wang
Tao Wang
SLShao-Hua Liu
Shao-Hua Liu
This study aimed to develop a modified Tessari method for producing more sclerosing foam in treatment of extensive venous malformations. Sclerosing foam was produced by using Tessari method and the modified Tessari method. The procedure of the later was as follows: prepared foam in a sclerosant–air ratio of 1:4; connected three disposable 10 ml syringes to two medical three-way taps; drawn 4 ml of liquid sclerosant into one syringe and 16 ml averagely of air into the other two; then moved the plungers of all syringes back and forth for 20 times to produce sclerosing foam. The volume and foam half time (FHT) of foam produced by the two methods were compared. The average volume of sclerosing foam produced by Tessari method and the modified Tessari method were 9.8 and 19.7 ml, and assessed to have statistical difference. The FHT of foam produced by the two methods were 120 and 150 s, and assessed to have statistical difference. In conclusion, the modified Tessari method could produce more fresh and stable sclerosing foam.

1 April 2021 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
YHY. Huang
Y. Huang
CYC. Yang
C. Yang
TWT. Wang
T. Wang
SLS. Liu
S. Liu
ACAnwei Chen
Anwei Chen

5 August 2020 in Dermatologic Surgery
Verified
Journal Article
Closed access
ZHZhang Hanshu
Zhang Hanshu
LSLiu Shaohua
Liu Shaohua
ACAnwei Chen
Anwei Chen
BACKGROUND: Foam sclerotherapy is an effective treatment strategy for venous malformations. Both polidocanol (POL) and bleomycin are effective sclerosants; however, no studies have reported POL–bleomycin foam. OBJECTIVE: To introduce a method for producing POL–bleomycin foam and evaluate the stability of POL–bleomycin foam with bleomycin concentrations. MATERIALS AND METHODS: Group A: 2 mL of 1% POL + 8 mL of air; Group B: 2 mL of 1% POL + 3 U bleomycin + 8 mL of air; Group C: 2 mL of 1% POL + 6 U bleomycin + 8 mL of air; Group D: 2 mL of 1% POL + 12 U bleomycin + 8 mL of air. Tessari method was used for foam generation. The foam half-life time (FHT) was used to evaluate foam stability. Five recordings were made for each group. RESULTS: The FHT was 148.6 ± 2.9 seconds in Group A, 148.8 ± 4.0 seconds in Group B, 148.4 ± 2.6 seconds in Group C, and 148.8 ± 1.6 seconds in Group D. The FHT in different groups showed no significant differences. CONCLUSION: The POL–bleomycin foam was prepared successfully and its FHT was as long as the POL foam.

1 July 2021 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
ACAnwei Chen
Anwei Chen

20 August 2026 in Dermatologic Surgery
Verified
Journal Article
Closed access
XMXiangzhen Meng
Xiangzhen Meng
TWTao Wang
Tao Wang
YLYiran Liu
Yiran Liu
SLShaohua Liu
Shaohua Liu
ACAnwei Chen
Anwei Chen
BACKGROUND: Foam sclerotherapy is effective for venous malformations, but the stability of physician-compounded foam is crucial. The effect of mesh pore size on stability remains unclear. OBJECTIVE: To investigate how varying mesh pore sizes affect foam stability and bubble morphology. MATERIALS AND METHODS: Foam was prepared using a double syringe system with 1% Polidocanol (1:4 ratio). Six groups were tested: 1 control (no mesh) and 5 experimental groups with meshes (40–160 mesh). Foam half-life time (FHT) and bubble diameter were measured. RESULTS: Meshes significantly increased FHT compared with the control ( p < .001). A smaller pore size correlated with longer FHT (up to 299 s) and smaller, more uniform bubbles (reduction of 44.95%–65.84% in diameter). CONCLUSION: Integrating a mesh into the double syringe system enhances foam stability. Smaller pore sizes produce finer, more stable foam, suggesting 40 to 160 mesh as the optimal clinical range.